Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002727306 | SCV003005784 | likely benign | Bethlem myopathy 1A | 2022-05-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004738605 | SCV005363637 | uncertain significance | COL6A3-related disorder | 2024-04-04 | no assertion criteria provided | clinical testing | The COL6A3 c.1250C>T variant is predicted to result in the amino acid substitution p.Pro417Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0050% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |